Swiss All Share Index
15.848,14
PKT
+74,77
PKT
+0,47
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.03.05 | Givaudan Underperform | HypoVereinsbank | |
| 02.03.05 | Holcim Neutral | Sarasin Research | |
| 03.03.05 | UBS Buy | SEB | |
| 03.03.05 | Nestlé Buy | Helvea | |
| 02.03.05 | Holcim Halten | Helaba Trust | |
| 03.03.05 | Nestlé Übergewichten | Bankhaus Reuschel & Co | |
| 03.03.05 | Holcim Accumulate | Helvea | |
| 01.03.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 03.03.05 | Baloise Outperform | Credit Suisse First Boston | |
| 02.03.05 | Givaudan Neutral | Helvea | |
| 01.03.05 | UBS Kaufen | Helaba Trust | |
| 01.03.05 | Nestlé Sector Outperform | Vontobel | |
| 02.03.05 | Holcim Outperform | Goldman Sachs | |
| 02.03.05 | Swiss Life Hold | Commerzbank | |
| 02.03.05 | Givaudan Neutral | Sarasin Research | |
| 01.03.05 | Nestlé Overweight | JP Morgan | |
| 01.03.05 | Swiss Life Buy | M.M. Warburg | |
| 01.03.05 | Swisscom Neutral | Helvea | |
| 01.03.05 | Schindler Buy | Sarasin Research | |
| 01.03.05 | Roche Buy | Sarasin Research | |
| 28.02.05 | Nestlé Akkumulieren | Independent Research | |
| 01.03.05 | Swiss Life Outperform | HypoVereinsbank | |
| 01.03.05 | Schindler Neutral | Helvea | |
| 25.02.05 | Holcim In-Line | Goldman Sachs | |
| 25.02.05 | UBS Buy | Commerzbank | |
| 25.02.05 | Nestlé In-Line | Goldman Sachs | |
| 25.02.05 | Holcim Overweight | JP Morgan | |
| 28.02.05 | Nestlé Buy | Sal. Oppenheim | |
| 28.02.05 | Nestlé Halten | Hamburger Sparkasse | |
| 28.02.05 | Nestlé Buy | Helvea | |
| 25.02.05 | Givaudan Neutral | Sarasin Research | |
| 25.02.05 | Temenos Market Outperform | Vontobel | |
| 24.02.05 | Novartis Overweight | Lehman Brothers | |
| 24.02.05 | Holcim Verkaufen | Helaba Trust | |
| 25.02.05 | Nestlé Neutral | Sarasin Research | |
| 25.02.05 | Nestlé Outperform | Credit Suisse First Boston | |
| 24.02.05 | Nestlé Buy | Helvea | |
| 25.02.05 | Nestlé Hold | SEB | |
| 24.02.05 | Zurich Insurance Accumulate | Helvea | |
| 23.02.05 | UBS Buy | Sarasin Research |